Cargando…
Iron Chelator Transmetalative Approach to Inhibit Human Ribonucleotide Reductase
[Image: see text] Efforts directed at curtailing the bioavailability of intracellular iron could lead to the development of broad-spectrum anticancer drugs given the metal’s role in cancer proliferation and metastasis. Human ribonucleotide reductase (RNR), the key enzyme responsible for synthesizing...
Autores principales: | Gaur, Kavita, Pérez Otero, Sofia C., Benjamín-Rivera, Josué A., Rodríguez, Israel, Loza-Rosas, Sergio A., Vázquez Salgado, Alexandra M., Akam, Eman A., Hernández-Matias, Liz, Sharma, Rohit K., Alicea, Nahiara, Kowaleff, Martin, Washington, Anthony V., Astashkin, Andrei V., Tomat, Elisa, Tinoco, Arthur D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243325/ https://www.ncbi.nlm.nih.gov/pubmed/34240081 http://dx.doi.org/10.1021/jacsau.1c00078 |
Ejemplares similares
-
Convergent allostery in ribonucleotide reductase
por: Thomas, William C., et al.
Publicado: (2019) -
Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy
por: Gaur, Kavita, et al.
Publicado: (2018) -
The periodic table of ribonucleotide reductases
por: Ruskoski, Terry B., et al.
Publicado: (2021) -
The tyrosyl free radical in ribonucleotide reductase.
por: Gräslund, A, et al.
Publicado: (1985) -
Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression
por: Mertens, Christina, et al.
Publicado: (2016)